TRINITY BIOTECH PLC(TRIB)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2024-12-31.

TRINITY BIOTECH PLC (TRIB) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores TRIB at 26.9/100 on a 32-signal composite quality model, placing it at rank #2,598 of 2,962 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (FY 2024), TRINITY BIOTECH PLC reports quarterly revenue of $61.6M, net income of $-31.2M. Top institutional holders of TRIB by reported 13-F value include HUNTER ASSOCIATES INVESTMENT MANAGEMENT, Williams & Novak, SUSQUEHANNA INTERNATIONAL GROUP, LLP, based on the most recent SEC filings. TRIB trades on the Nasdaq exchange and files with the SEC under CIK 888721. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate TRIB daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for TRINITY BIOTECH PLC directly from SEC EDGAR.